Mumbai: Glenmark Pharmaceuticals Friday said the shareholders of the company have agreed to raise $250 million.
The company would raise the amount through global depository receipts, American depository receipts and foreign currency convertible bonds or by private placement of shares or by qualified institutional investors, Glenmark said in a statement.
